ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Swedish specialty chemicals maker Perstorp is buying Solvay's caprolactones unit for about $285 million. Perstorp says the business is the largest of its kind in the world. Solvay makes e-caprolactone at a plant in Warrington, England. Major uses of e-caprolactone include making polyols for producing polyurethanes for shoe soles and medical splints. The Solvay business employs 65 people and generated revenues of $85 million in 2006. Solvay says the unit has no significant synergies with Solvay's other pharmaceutical, chemical, and plastics businesses. Moreover, the company doesn't make cyclohexanone, the key raw material for e-caprolactone. Perstorp doesn't make cyclohexanone either, but it does make polyols that go into applications similar to those derived from e-caprolactone. Pending the expected completion of the deal in the fourth quarter of this year, Perstorp plans to double capacity for e-caprolactone and expand capacity for downstream polyols and other polymers.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter